View in EDS HTML Full Text PDF Full Text

Tbx5 variants disrupt Nav1.5 function differently in patients diagnosed with Brugada or Long QT Syndrome.

Saved in:
Bibliographic Details
Title: Tbx5 variants disrupt Nav1.5 function differently in patients diagnosed with Brugada or Long QT Syndrome.
Authors: Nieto-Marín P; Department of Pharmacology and Toxicology, School of Medicine, Universidad Complutense de Madrid. Instituto de Investigación Gregorio Marañón. CIBERCV, Madrid 28040, Spain., Tinaquero D; Department of Pharmacology and Toxicology, School of Medicine, Universidad Complutense de Madrid. Instituto de Investigación Gregorio Marañón. CIBERCV, Madrid 28040, Spain., Utrilla RG; Department of Pharmacology and Toxicology, School of Medicine, Universidad Complutense de Madrid. Instituto de Investigación Gregorio Marañón. CIBERCV, Madrid 28040, Spain., Cebrián J; Department of Pharmacology and Toxicology, School of Medicine, Universidad Complutense de Madrid. Instituto de Investigación Gregorio Marañón. CIBERCV, Madrid 28040, Spain., González-Guerra A; Fundación Centro Nacional de Investigaciones Cardiovasculares. CIBERCV, Madrid 28029, Spain., Crespo-García T; Department of Pharmacology and Toxicology, School of Medicine, Universidad Complutense de Madrid. Instituto de Investigación Gregorio Marañón. CIBERCV, Madrid 28040, Spain., Cámara-Checa A; Department of Pharmacology and Toxicology, School of Medicine, Universidad Complutense de Madrid. Instituto de Investigación Gregorio Marañón. CIBERCV, Madrid 28040, Spain., Rubio-Alarcón M; Department of Pharmacology and Toxicology, School of Medicine, Universidad Complutense de Madrid. Instituto de Investigación Gregorio Marañón. CIBERCV, Madrid 28040, Spain., Dago M; Department of Pharmacology and Toxicology, School of Medicine, Universidad Complutense de Madrid. Instituto de Investigación Gregorio Marañón. CIBERCV, Madrid 28040, Spain., Alfayate S; Department of Pharmacology and Toxicology, School of Medicine, Universidad Complutense de Madrid. Instituto de Investigación Gregorio Marañón. CIBERCV, Madrid 28040, Spain., Filgueiras-Rama D; Fundación Centro Nacional de Investigaciones Cardiovasculares. CIBERCV, Madrid 28029, Spain., Peinado R; Department of Cardiology, Hospital Universitario La Paz. Instituto de Investigación Sanitaria la Paz. CIBERCV, Madrid 28046, Spain., López-Sendón JL; Department of Cardiology, Hospital Universitario La Paz. Instituto de Investigación Sanitaria la Paz. CIBERCV, Madrid 28046, Spain., Jalife J; Fundación Centro Nacional de Investigaciones Cardiovasculares. CIBERCV, Madrid 28029, Spain.; Departments of Internal Medicine and Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI, USA., Tamargo J; Department of Pharmacology and Toxicology, School of Medicine, Universidad Complutense de Madrid. Instituto de Investigación Gregorio Marañón. CIBERCV, Madrid 28040, Spain., Bernal JA; Fundación Centro Nacional de Investigaciones Cardiovasculares. CIBERCV, Madrid 28029, Spain., Caballero R; Department of Pharmacology and Toxicology, School of Medicine, Universidad Complutense de Madrid. Instituto de Investigación Gregorio Marañón. CIBERCV, Madrid 28040, Spain., Delpón E; Department of Pharmacology and Toxicology, School of Medicine, Universidad Complutense de Madrid. Instituto de Investigación Gregorio Marañón. CIBERCV, Madrid 28040, Spain.
Corporate Authors: ITACA Consortium Investigators
Source: Cardiovascular research [Cardiovasc Res] 2022 Mar 16; Vol. 118 (4), pp. 1046-1060.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford Journals Country of Publication: England NLM ID: 0077427 Publication Model: Print Cited Medium: Internet ISSN: 1755-3245 (Electronic) Linking ISSN: 00086363 NLM ISO Abbreviation: Cardiovasc Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1755-3245
DOI:10.1093/cvr/cvab045